PSMA PET-CT y cinéticas del PSA: optimizando el uso de una herramienta poderosa

PSMA PET-CT y cinéticas del PSA: optimizando el uso de una herramienta poderosa

Bibliographic Details
Main Author:	Marcelo Clariá
Format:	Article
Language:	English
Published:	Publicaciones Permanyer 2022-07-01
Series:	Revista Argentina de Radiología
Online Access:	https://www.revistarar.com/frame_esp.php?id=51

Similar Items

Pretest PSA and Restaging PSMA PET/CT Predict Survival in Biochemically Recurrent Prostate Cancer
by: Rie von Eyben, et al.
Published: (2023-08-01)

Endosonografía (EUS) y punción con aguja fina (FNA). Una poderosa herramienta clínica
by: Cecilia Castillo Taucher
Published: (2008-01-01)

A Risk Model for Patients with PSA-Only Recurrence (Biochemical Recurrence) Based on PSA and PSMA PET/CT: An Individual Patient Data Meta-Analysis
by: Rie von Eyben, et al.
Published: (2022-11-01)

PSA and PSA Kinetics Thresholds for the Presence of <sup>68</sup>Ga-PSMA-11 PET/CT-Detectable Lesions in Patients with Biochemical Recurrent Prostate Cancer
by: Manuela Andrea Hoffmann, et al.
Published: (2020-02-01)

<sup>68</sup>Ga-PSMA PET/CT for Patients with PSA Relapse after Radical Prostatectomy or External Beam Radiotherapy
by: Finn Edler von Eyben, et al.
Published: (2021-03-01)

La tecnología digital como herramienta para la democratización de ideas matemáticas poderosas
by: Santiago Palmas Pérez
Published: (2018-01-01)

Can the Gleason score be predicted in patients with prostate cancer? A dynamic contrast-enhanced MRI, (68)Ga-PSMA PET/CT, PSA, and PSA-density comparison study
by: Hüseyin Akkaya, et al.
Published: (2023-09-01)

Comparison of [<sup>18</sup>F]PSMA-1007 with [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT in Restaging of Prostate Cancer Patients with PSA Relapse
by: Manuela A. Hoffmann, et al.
Published: (2022-03-01)

Meta-analysis of 18 F-PSMA-1007 PET/CT, 18 F-FDG PET/CT, and 68Ga-PSMA PET/CT in diagnostic efficacy of prostate Cancer
by: Wenxiao Yu, et al.
Published: (2023-08-01)

Optimizando el uso de tubo orotraqueal y máscara laríngea en paciente pediátrico
by: Magdalena Raggio, et al.
Published: (2022-07-01)

PSMA PET-CT in the Diagnosis and Staging of Prostate Cancer
by: Alexander D. Combes, et al.
Published: (2022-10-01)

La enfermería, acoplada y poderosa
by: Luz Patricia Diaz Heredia
Published: (2017-09-01)

The Impact of PSMA-PET on Oncologic Control in Prostate Cancer Patients Who Experienced PSA Persistence or Recurrence
by: Lorenzo Bianchi, et al.
Published: (2022-12-01)

68Ga-PSMA PET/CT-based multivariate model for highly accurate and noninvasive diagnosis of clinically significant prostate cancer in the PSA gray zone
by: Jinhui Yang, et al.
Published: (2023-09-01)

Ductal prostate cancer staging: Role of PSMA PET/CT
by: Pietro Pepe, et al.
Published: (2024-02-01)

Irreversible electroporation for prostate cancer using PSMA PET-CT
by: Dongho Shin, et al.
Published: (2023-03-01)

Correlación entre las cinéticas del PSA y positividad de la tomografía por emisión de positrones 18F-PSMA-1007 en la reestadificación de la recaída del cáncer de próstata
by: Miguel A. Bergero, et al.
Published: (2022-07-01)

Prospective evaluation of radical prostatectomy without prior biopsy based on PSA or DRE, mpMRI and PSMA-PET
by: C. Stief, et al.
Published: (2023-11-01)

Multiparametric dynamic whole-body PSMA PET/CT using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007
by: André H. Dias, et al.
Published: (2023-04-01)

PSMA PET/CT in Renal Cell Carcinoma: An Overview of Current Literature
by: Stijn Muselaers, et al.
Published: (2022-03-01)

PSMA PET/CT in Castration-Resistant Prostate Cancer: Myth or Reality?
by: Luca Urso, et al.
Published: (2023-11-01)

PSMA-Positive Low Malignant Gastrointestinal Stromal Tumor in the Stomach on F-18-PSMA-1007 PET/CT
by: Peter Iversen, et al.
Published: (2022-01-01)

ENFERMERÍA PROFESIÓN DE NIVEL, COMPROMETIDA Y PODEROSA
by: Mirtha Flor Cervera Vallejos
Published: (2018-07-01)

ENFERMERÍA PROFESIÓN DE NIVEL, COMPROMETIDA Y PODEROSA
by: Mirtha Flor Cervera Vallejos
Published: (2018-07-01)

<sup>68</sup>Ga-PSMA-11 PET/CT-Guided Stereotactic Body Radiation Therapy Retreatment in Prostate Cancer Patients with PSA Failure after Salvage Radiotherapy
by: Paola Caroli, et al.
Published: (2020-11-01)

Primary Staging of Prostate Cancer Patients with [<sup>18</sup>F]PSMA-1007 PET/CT Compared with [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT
by: Manuela A. Hoffmann, et al.
Published: (2022-08-01)

Optimizando el acceso a los directorios de la microcomputadora
by: Freddy Abarca-R.
Published: (2019-02-01)

Pretherapeutic PSMA PET-Derived Semiquantitative Parameters as Predictors of PSA Response in Patients with mCRPC Receiving [<sup>177</sup>Lu]Lu-PSMA-617 Radioligand Therapy
by: Dheeratama Siripongsatian, et al.

Prostate cancer brain metastases: Monitoring response to treatment with PSMA PET/CT
by: Anas Al-Zubaidi, MD, et al.
Published: (2024-06-01)

Can PSMA PET/CT help in dose-tailoring in post-prostatectomy radiotherapy?
by: Ambroise Champion, et al.
Published: (2023-09-01)

Review of Gallium-68 PSMA PET/CT Imaging in the Management of Prostate Cancer
by: Nat P. Lenzo, et al.
Published: (2018-02-01)

The clinical application of 68Ga-PSMA PET/CT and regulating mechanism of PSMA expression in patients with brain metastases of lung cancer
by: Yuchen Pei, et al.
Published: (2023-02-01)

Viagem de incentivo - uma poderosa ferramenta de marketing
by: Jean-François L. M. Hue
Published: (1992-11-01)

[89Zr]Zr-PSMA-617 PET/CT characterization of indeterminate [68Ga]Ga-PSMA-11 PET/CT findings in patients with biochemical recurrence of prostate cancer: lesion-based analysis
by: Florian Rosar, et al.
Published: (2024-02-01)

Atypical metastases from prostate cancer detected on 68Ga-PSMA PET/CT: a case series
by: Lilian Yuri Itaya Yamaga, et al.
Published: (2020-11-01)

Hybrid imaging with [68Ga]PSMA-11 PET-CT and PET-MRI in biochemically recurrent prostate cancer
by: P. A. Glemser, et al.
Published: (2022-09-01)

PSMA Receptor-Based PET-CT: The Basics and Current Status in Clinical and Research Applications
by: Aadil Adnan, et al.
Published: (2023-01-01)

Performance of Ga-68 PSMA PET/CT for diagnosis and grading of local prostate cancer
by: Timothy N. Kwan, et al.
Published: (2021-06-01)

Correction: von Eyben et al. A Risk Model for Patients with PSA-Only Recurrence (Biochemical Recurrence) Based on PSA and PSMA PET/CT: An Individual Patient Data Meta-Analysis. <i>Cancers</i> 2022, <i>14</i>, 5461
by: Rie von Eyben, et al.
Published: (2023-02-01)

Histologically Confirmed Testicular Metastasis Revealed by [<sup>89</sup>Zr]Zr-PSMA-617 PET/CT in a Patient with Biochemical Recurrence of Prostate Cancer and Negative Conventional PSMA PET/CT Imaging
by: Florian Rosar, et al.
Published: (2023-04-01)